Gilead Sciences Inc (NASDAQ:GILD)
| 74.99 Delayed Data As of Sep 22 |  -0.28 / -0.37%Today’s Change | 61.45 Today|||52-Week Range 89.74 | -12.65% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 5.6B | 5.8B | 5.3B | 5.6B | |
| Cost of Goods Sold | 728.0M | 1.2B | 598.0M | 652.0M | ||
| Depreciation And Amortization | 358.0M | 358.0M | 359.0M | 348.0M | ||
| Operating Expenses | Gross Income | 4.5B | 4.2B | 4.3B | 4.6B | |
| General Expenses | 1.9B | 2.3B | 2.1B | 2.3B | ||
| Research And Development | 939.0M | 1.1B | 1.1B | 1.2B | ||
| Total Operating Expenses | 3.0B | 3.8B | 3.0B | 3.3B | ||
| Non-Operating Expenses | Operating Income | 2.6B | 2.0B | 2.2B | 2.4B | |
| Extraordinary Credit | 183.0M | 0.00 | 191.0M | 52.0M | ||
| Extraordinary Charge | -- | -867.0M | -- | -- | ||
| Interest Expense On Debt | 264.0M | 257.0M | 254.0M | 248.0M | ||
| Other Expenses | 114.0M | 190.0M | 205.0M | 212.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 2.7B | 1.0B | 2.4B | 2.4B | |
| Income Taxes | -565.0M | -1.0B | -382.0M | -535.0M | ||
| Minority Interest | -2.0M | 0.00 | -7.0M | -5.0M | ||
| Net Income | 2.1B | 3.0M | 2.0B | 1.9B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.3B | 1.3B | 1.3B | 1.3B | |
| Shares To Calculate EPS Diluted | 1.3B | 1.3B | 1.3B | 1.3B | ||
| Earnings Per Share | EPS | $1.60 | $0.00 | $1.54 | $1.47 | |
| EPS Diluted | $1.60 | $0.00 | $1.54 | $1.47 | ||
